Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging

Monticciolo, Debra L.; Malak, Sharp F.; Friedewald, Sarah M.; Eby, Peter R.; Newell, Mary S.; Moy, Linda; Destounis, Stamatia; Leung, Jessica W.T.; Hendrick, R. Edward; Smetherman, Dana H.

doi:10.1016/j.jacr.2021.04.021

Cited by 131 publications

(79 citation statements)

References 106 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar patterns for Asian women have been noted for other screening services, including cervical cancer [ 7 ]. Much of the focus on race/ethnicity in breast cancer screening outreach efforts unrelated to the pandemic has been directed toward black women because of their high rates of breast cancer and generally worse outcomes [ 22 ]. But our results suggest that outreach efforts directed toward the Asian community are important as well.…”

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database

Grimm

Lee

Rosenberg

et al. 2022

Journal of the American College of Radiology

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database

Grimm

Lee

Rosenberg

et al. 2022

Journal of the American College of Radiology

Self Cite

View full text Add to dashboard Cite

“…1,[3][4][5][6] Organizations that recommend initiating screening at age 40 years emphasize life-years saved rather than mortality reduction alone, as individuals in their 40s have a higher potential number of life-years lost from breast cancer than older individuals despite the absolute cancer risk being smaller. 1,6 There is evidence to suggest that deferring screening until age 50 may disproportionately affect non-White racial/ethnic groups given a higher proportion of breast cancer cases diagnosed before age 50 in non-White populations. 6,7 The risks of screening mammography include the risk of recalls, false-positive results, psychosocial harm, and overdiagnosis.…”

Section: Average-risk Screeningmentioning

confidence: 99%

“…There is observational data that the mortality benefit of screening likely persists into the elderly population. 1,3,4,6 These potential benefits, however, must be individualized based on one's other medical comorbidities and health status.…”

Section: Average-risk Screeningmentioning

confidence: 99%

“…This most recent update incorporated data on disparities in breast cancer screening, treatment, and outcomes. 6 The ACR and SBI recommend all individuals undergo a risk assessment by age 30 years to identify those at increased risk. Annual screening mammography is recommended starting at age 40 years, as this screening regimen is associated with the greatest reduction in breast cancer mortality, earlier stage at diagnosis, and more favorable treatment options.…”

Section: American College Of Radiology (Acr)/society Of Breast Imagin...mentioning

confidence: 99%

See 1 more Smart Citation

Breast Cancer Screening: An Overview of Risk-specific Screening and Risk Assessment

Scott

2022

Clinical Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

Breast cancer screening decreases stage at diagnosis, treatment morbidity, and disease mortality. A comprehensive risk assessment is critical to determine an individual's most appropriate screening regimen. Multiple guidelines exist for screening mammography in average-risk individuals, which differ on age and frequency of screening. Annual mammography starting at age 40 is associated with the greatest reduction in breast cancer mortality and greatest number of life-years saved. A formal risk calculator is helpful to assess one's lifetime risk of breast cancer and assess eligibility for high-risk screening. Screening guidelines exist for genetic mutations that increase breast cancer risk.

show abstract

“…The added yield from MRI, averaging 10 to 16 cancers per 1000 women screened, [8][9][10] far exceeds that from ultrasound at 2 to 3 per 1000, [11][12][13] but MRI is not available for all women with dense breasts at this time. As Monticciolo et al 14 have pointed out, a risk assessment should be performed for all women by the age of 30 years so that women at high risk can begin screening with MRI if that is appropriate. Women of Ashkenazi Jewish heritage and Women of Color are especially encouraged to seek a formal risk assessment by the age of 30 years, possibly including testing for pathogenic mutations.…”

mentioning

confidence: 99%

Corrections: Breast cancer screening guidelines for young women of color

Gordon¹,

Berg

2021

Cancer

View full text Add to dashboard Cite

We enjoyed reading Hendrick et al's important article entitled "Age Distributions of Breast Cancer Diagnosis and Mortality by Race and Ethnicity in US Women" 1 and the accompanying editorial by Yaffe. 2 We write, however, to point out several important errors in the editorial by Seewaldt and Bernstein. 3 They incorrectly cite Stapleton et al 4 as stating that "for Black, Asian, and Hispanic/Latina women, the diagnosis of invasive breast cancer peaked at the age of 40 years (vs the mid-60s for NH-White women)." The actual statement is that "the median age at diagnosis was 59 years for White (IQR, 51-67 years), 56 years for Black (IQR, 49-65 years), 55 years for Hispanic (IQR, 48-64 years), and 56 years for Asian patients (IQR, 48-64 years) (Figure 1)." Figure 1 shows that the "peak" is in the mid to late 40s for Women of Color.Citing an advocacy website, 5 they also incorrectly state that "all 50 states in the United States have enacted legislation requiring radiologists to inform women of all races and ethnicities who have high breast density that they 1) are at increased breast cancer risk and 2) may benefit from supplemental breast cancer screening modalities, such as whole breast screening ultrasound." The federal law passed in 2019 ensured that the Food and Drug Administration process of updating postmammography reporting requirements for both patients and referring physicians would move forward. To date, the Food and Drug Administration has not introduced a federal standard. 6 Individual state "inform" requirements are still accomplished through individual state laws. Currently, 38 states and the District of Columbia 7 have active density inform laws, but they vary in the depth and breadth of information required to be provided to women. For instance, not all mention increased risk or supplemental screening or even require mammography facilities to inform a given woman that she has dense breasts. The outcomes of breast cancer in women with dense breasts are, in fact, worse in the cited analysis of Gierach et al 8 with an excess of late-stage (II and III) disease. The relatively short mean follow-up of 6.6 years was insufficient for an accurate analysis of mortality after screening.

show abstract

Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging

Cited by 131 publications

References 106 publications

Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database

Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database

Breast Cancer Screening: An Overview of Risk-specific Screening and Risk Assessment

Corrections: Breast cancer screening guidelines for young women of color

Contact Info

Product

Resources

About